Особенности клинического течения синдрома тиреотоксикоза среди кардиологических больных Хайитбоева к.х.

Хайитбоева К.Х

Марказий Осиё эндокринологик журнали · 2022-yil

Annotatsiya

Diffuse toxic goiter is a disease that is characterized by increased production of thyroid hormones and diffuse enlargement of the thyroid gland, like all autoimmune diseases, it is more common in patients with a positive family history, this is caused by environmental factors such as stress, smoking, infection, iodine exposure and the postpartum period, and after highly active antiretroviral therapy due to immune reconstitution, which primarily affects the thyroid gland. The aim of the study is to determine the frequency of occurrence of diffuse toxic goiter among cardiac patients and to assess its clinical course. Materials and methods. The collection of clinical material was carried out within 6 months, from January to July 2022, the collection of material was carried out in the Specialized Scientific and Practical Medical Center of Cardiology and Cardiac Surgery of the Aral Region. We consulted 1150 patients who were referred by cardiologists to rule out thyroid diseases. Results. Out of 1150 patients, 71 patients (6.2%) had diseases occurring with thyrotoxicosis syndrome. When analyzing hormonal and immunological data, DTG was diagnosed in 24 (33.8%) patients. The majority of patients are women - 70.8%. Conclusions. It turned out that many patients with DTG with cardiovascular pathology turn to a cardiologist at the onset of the disease (37.5% of newly diagnosed DTG).

Maqola ma’lumotlari
MualliflarХайитбоева К.Х
JurnalМарказий Осиё эндокринологик журнали
NashriyotРеспублика ихтисослаштирилган эндокринология илмий-амалий тиббиёт маркази
ISSN2181-3426
Nashr sanasi2022-12-24
Jild2
Son2
TilRus
Ilmiy sohaTibbiyot
Indeksga qo‘shilgan2026-09-13

Maqolaning asl sahifasi

Kalit so‘zlar

синдром тиреотоксикоза; среди кардиологических больных; диффузный токсический зоб; иммунологический маркер, тиреотоксикоз синдроми; кардиологик беморлар орасида; диффуз токсик бўқоқ; иммунологик маркер, thyrotoxicosis syndrome; among cardiac patients; diffuse toxic goiter; immunological marker

Ilmiy soha

Tibbiyot

Iqtibos keltirish

APAХайитбоева К.Х (2022). ОСОБЕННОСТИ КЛИНИЧЕСКОГО ТЕЧЕНИЯ СИНДРОМА ТИРЕОТОКСИКОЗА СРЕДИ КАРДИОЛОГИЧЕСКИХ БОЛЬНЫХ Хайитбоева К.Х.. Марказий Осиё эндокринологик журнали, 2(2). https://www.tadqiqot.uz/index.php/cae/article/view/6186
GOST (OAK)Хайитбоева К.Х ОСОБЕННОСТИ КЛИНИЧЕСКОГО ТЕЧЕНИЯ СИНДРОМА ТИРЕОТОКСИКОЗА СРЕДИ КАРДИОЛОГИЧЕСКИХ БОЛЬНЫХ Хайитбоева К.Х. // Марказий Осиё эндокринологик журнали. – 2022. – T. 2, № 2.
MLAХайитбоева К.Х. “ОСОБЕННОСТИ КЛИНИЧЕСКОГО ТЕЧЕНИЯ СИНДРОМА ТИРЕОТОКСИКОЗА СРЕДИ КАРДИОЛОГИЧЕСКИХ БОЛЬНЫХ Хайитбоева К.Х..” Марказий Осиё эндокринологик журнали, 2(2), 2022. https://www.tadqiqot.uz/index.php/cae/article/view/6186
ChicagoХайитбоева К.Х. “ОСОБЕННОСТИ КЛИНИЧЕСКОГО ТЕЧЕНИЯ СИНДРОМА ТИРЕОТОКСИКОЗА СРЕДИ КАРДИОЛОГИЧЕСКИХ БОЛЬНЫХ Хайитбоева К.Х..” Марказий Осиё эндокринологик журнали, 2(2) (2022). https://www.tadqiqot.uz/index.php/cae/article/view/6186
HarvardХайитбоева К.Х (2022) ‘ОСОБЕННОСТИ КЛИНИЧЕСКОГО ТЕЧЕНИЯ СИНДРОМА ТИРЕОТОКСИКОЗА СРЕДИ КАРДИОЛОГИЧЕСКИХ БОЛЬНЫХ Хайитбоева К.Х.’, Марказий Осиё эндокринологик журнали, 2(2). https://www.tadqiqot.uz/index.php/cae/article/view/6186
BibTeX
@article{article2022,
  title = {ОСОБЕННОСТИ КЛИНИЧЕСКОГО ТЕЧЕНИЯ СИНДРОМА ТИРЕОТОКСИКОЗА СРЕДИ КАРДИОЛОГИЧЕСКИХ БОЛЬНЫХ Хайитбоева К.Х.},
  author = {Хайитбоева К.Х},
  journal = {Марказий Осиё эндокринологик журнали},
  year = {2022},
  volume = {2},
  number = {2},
  url = {https://www.tadqiqot.uz/index.php/cae/article/view/6186}
}

Boshqa maqola uchun iqtibos tayyorlash

Марказий Осиё эндокринологик журнали jurnalidan boshqa maqolalar

Марказий Осиё эндокринологик журнали — barcha maqolalar · 2022-yil arxivi

Хайитбоева К.Х — boshqa maqolalari

Tibbiyot sohasidagi boshqa maqolalar

Tibbiyot sohasidagi OAK jurnallari